Several case studies will be presented to illustrate Amgen’s perspective of the process development. We strongly believe that the science and innovation is the foundation to develop the cost effective and robust synthetic routes, mitigate the potential supply risk, deliver quality therapeutics to patients, and maintain profits in the wake of patent expiry and generic competition.

Science and innovation in API process design and continuous improvement

254th National Meeting (2017)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.